News
9d
The Monterey County Herald on MSNHerald Heroes: Julie Kelly builds connections, both in and out of the classroomHer advocacy for students, mentorship of new teachers, and contributions to school committees all reflect her commitment to a ...
8d
TheJournal.ie on MSNGrowth, jobs, wages: there are plenty of positives on the sunny side of Ireland's economyWages are up, inflation is down, we’ve all got jobs. Paul O’Donoghue takes a look at the upsides of Ireland’s economy.
Five years since the pandemic began, millions of people are still grappling with long covid, even as new patients are joining their ranks. “Considering how far along we are and how tens of ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability later ...
May 19, 2025 – The FDA has approved the Novavax COVID-19 vaccine, a protein-based alternative to mRNA shots, with some limits on who can get it. The vaccine, called Nuvaxovid, is mainly ...
About 12M long COVID patients have reported 'brain fog' New study examined 17 people, including 10 with neurological symptoms Findings validate the experiences of 'long-haulers' About 12M long ...
Hong Kong and Singapore are experiencing a resurgence of Covid-19 infections, driven by waning immunity and the spread of Omicron JN.1 variants. Hong Kong's infection rates have surged past ...
WASHINGTON (AP) — Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to ...
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious ...
As cases of long COVID — often defined as symptoms that weren’t present before persisting for 3 or more months after the infection — became more prevalent and alarming, researchers began to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results